The Ablation Technologies Market size in the Middle East & Africa has been valued at USD 297.44 Million in 2021 and is projected to reach USD 510.30 Million by 2026, at a CAGR of 11.40% between 2021 to 2026.
The ablation devices are consisting of catheters, generators, and other monitoring equipment. As ablation surgeries are minimally invasive, it reduces post-surgical complications and gives more accurate and successful results; therefore the market for ablation technologies has high growth potential in the coming future.
The market for Ablation Technologies is mainly driven due to an increased number of hospitals, ablation, and surgical centers, a rising number of training programs, an increasing patient base in emerging economies, and increased investment for the development of ablation devices, improving reimbursement scenario. But the market growth can be restrained due to a lack of properly skilled labor and stringent regulatory framework for ablation technologies.
The market in this region is growing with high CAGR due to ongoing technological advancements, a huge patient base, and improving healthcare infrastructure, creating a wide range of opportunities for market players to expand their business in the untapped areas of this region.
This research report on the MEA Ablation Technologies Market has been segmented and sub-segmented into the following categories.
By Product:
By Type:
By Application:
By Country:
Based on type, the Radiofrequency-based ablation technology segment is expected to lead the European ablation technologies market.
Based on application, a large market share is attributed to the cardiovascular disease treatment segment.
Key Market Companies leading the Middle East & Africa Ablation Technologies Market Profiled in the Report are Biosense Webster, Inc., St. Jude Medical, Inc., Boston Scientific Corporation, AngioDynamics, Inc., AtriCure, Inc., Smith & Nephew plc, Galil Medical Inc., CONMED Corporation, Olympus Corporation, Covidien PLC, Medtronic, Inc., and BSD Medical Corporation.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 Light/Laser ablators
5.1.2.1 Excimer laser ablators
5.1.2.2 Cold laser ablators
5.1.3 Radiofrequency (RF) ablators
5.1.3.1 Temperature-controlled RF ablators
5.1.3.2 Fluid-cooled RF ablators
5.1.3.3 Robotic catheter manipulation systems
5.1.4 Electrical ablators
5.1.4.1 Argon plasma/beam coagulators
5.1.4.2 Irreversible electroporation ablators
5.1.5 Ultrasound ablators
5.1.5.1 High-intensity focused ultrasound (HIFU) ablators
5.1.5.2 Magnetic resonance guided focused ultrasound (MRGFUS) ablators
5.1.5.3 Ultrasonic surgical ablation systems
5.1.5.4 Extracorporeal shockwave lithotripsy systems
5.1.6 Microwave ablators
5.1.6.1 Microwave thermotherapy ablators
5.1.7 Cryoablation devices
5.1.7.1 Tissue contact probe ablators
5.1.7.2 Tissue spray probe ablators
5.1.7.3 Epidermal and subcutaneous cryoablation systems
5.1.8 Hydrothermal ablators
5.1.8.1 Endothermal hydrothermal balloon ablation devices
5.1.9 Y-o-Y Growth Analysis, By Product
5.1.10 Market Attractiveness Analysis, By Product
5.1.11 Market Share Analysis, By Product
5.2 Type
5.2.1 Introduction
5.2.2 Light/Laser Ablation
5.2.3 Radiofrequency Ablation
5.2.4 Electrical Ablation
5.2.5 Ultrasound Ablation
5.2.6 Cryoablation
5.2.7 Microwave Ablation
5.2.8 Hydrothermal Ablation
5.2.9 Y-o-Y Growth Analysis, By Type
5.2.10 Market Attractiveness Analysis, By Type
5.2.11 Market Share Analysis, By Type
5.3 Application
5.3.1 Introduction
5.3.2 Cardiovascular Disease Treatment
5.3.3 Cancer Treatment
5.3.4 Ophthalmologic Treatment
5.3.5 Gynecologic Treatment
5.3.6 Pain Management
5.3.7 Urologic Treatment
5.3.8 Orthopedic Treatment
5.3.9 Cosmetic Surgery
5.3.10 Other Treatments
5.3.11 Y-o-Y Growth Analysis, By Application
5.3.12 Market Attractiveness Analysis, By Application
5.3.13 Market Share Analysis, By Application
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Type
6.1.3.4 By Application
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Type
6.1.4.4 By Application
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Type
6.1.5.4 By Application
6.2 Middle-East
6.3 Africa
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Biosense Webster, Inc.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 St. Jude Medical, Inc.
8.3 Boston Scientific Corporation
8.4 AngioDynamics, Inc.
8.5 AtriCure, Inc.
8.6 Smith & Nephew plc
8.7 Galil Medical Inc.
8.8 CONMED Corporation
8.9 Olympus Corporation
8.10 Covidien PLC
8.11 Medtronic, Inc.
8.12 BSD Medical Corporation
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
